Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCM Combined With Chemotherapy in Advanced NSCLC
NCT02777788Phase 3Unknown
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Sep 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of jinfukang and xingzaoruanjian in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: Progression-Free Survival at 2 months. Status: unknown.
02
Drugs
jinfukangxingzaoruanjian
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02777788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02777788.